These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22963553)

  • 1. Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD.
    Montuschi P; Macagno F; Valente S; Fuso L
    Curr Med Chem; 2013; 20(12):1464-76. PubMed ID: 22963553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends.
    Montuschi P; Ciabattoni G
    J Med Chem; 2015 May; 58(10):4131-64. PubMed ID: 25587755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF
    Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic Receptor Antagonists.
    Matera MG; Cazzola M
    Handb Exp Pharmacol; 2017; 237():41-62. PubMed ID: 27787709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
    Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
    Blasi F; Canonica GW; Miravitlles M
    Respir Res; 2017 Jan; 18(1):19. PubMed ID: 28100244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
    Gupta V; Singh D
    Expert Rev Respir Med; 2012 Dec; 6(6):581-8. PubMed ID: 23234445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD.
    Hansel TT; Barnes PJ
    Drugs Today (Barc); 2002 Sep; 38(9):585-600. PubMed ID: 12582447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic antagonists in early stage clinical development for the treatment of asthma.
    Albertson TE; Chenoweth JA; Adams JY; Sutter ME
    Expert Opin Investig Drugs; 2017 Jan; 26(1):35-49. PubMed ID: 27927039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.
    Mastrodicasa MA; Droege CA; Mulhall AM; Ernst NE; Panos RJ; Zafar MA
    Expert Opin Investig Drugs; 2017 Feb; 26(2):161-174. PubMed ID: 28004591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
    Malerba M; Radaeli A; Santini G; Morjaria J; Mores N; Mondino C; Macis G; Montuschi P
    Expert Opin Drug Discov; 2018 Jun; 13(6):563-577. PubMed ID: 29616842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy.
    Calzetta L; Matera MG; Cazzola M
    Eur J Pharmacol; 2015 Aug; 761():168-73. PubMed ID: 25981302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
    Fuso L; Mores N; Valente S; Malerba M; Montuschi P
    Curr Med Chem; 2013; 20(12):1477-95. PubMed ID: 23409722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
    Di Marco F; Santus P; Scichilone N; Solidoro P; Contoli M; Braido F; Corsico AG
    Respir Med; 2017 Apr; 125():49-56. PubMed ID: 28340862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.
    Maltais F; Milot J
    Ther Adv Respir Dis; 2012 Dec; 6(6):345-61. PubMed ID: 23075544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety.
    Ridolo E; Montagni M; Riario-Sforza GG; Baroni M; Incorvaia C
    Ther Adv Respir Dis; 2015 Apr; 9(2):49-55. PubMed ID: 25691493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.